beta-lapachone and vitamin k semiquinone radical

beta-lapachone has been researched along with vitamin k semiquinone radical in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Frydman, B; Liu, AA; Liu, LF; Mao, Y; Marton, LJ; Neder, K; Sanders, MM; Sun, JS; Wang, HM; Witiak, DT; Wu, HY	1
Boothman, DA; Pink, JJ; Planchon, SM; Siegel, D; Tagliarino, C; Varnes, ME	1

Other Studies

2 other study(ies) available for beta-lapachone and vitamin k semiquinone radical

Article	Year
Induction of DNA topoisomerase II-mediated DNA cleavage by beta-lapachone and related naphthoquinones. Cancer research, 1997, Feb-15, Volume: 57, Issue:4 Topics: Antineoplastic Agents, Alkylating; Camptothecin; DNA; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Humans; Mercaptoethanol; Naphthoquinones; Reverse Transcriptase Inhibitors; Topoisomerase I Inhibitors; Vitamin K; Yeasts	1997
NAD(P)H:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity. The Journal of biological chemistry, 2000, Feb-25, Volume: 275, Issue:8 Topics: Antibiotics, Antineoplastic; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Division; Cytochrome Reductases; Cytochrome-B(5) Reductase; Dicumarol; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Flow Cytometry; Humans; Models, Biological; NAD; NADH, NADPH Oxidoreductases; NADPH-Ferrihemoprotein Reductase; Naphthoquinones; Proteins; Quinone Reductases; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Vitamin K	2000

Article

Year

Induction of DNA topoisomerase II-mediated DNA cleavage by beta-lapachone and related naphthoquinones.

Cancer research, 1997, Feb-15, Volume: 57, Issue:4

Topics: Antineoplastic Agents, Alkylating; Camptothecin; DNA; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Humans; Mercaptoethanol; Naphthoquinones; Reverse Transcriptase Inhibitors; Topoisomerase I Inhibitors; Vitamin K; Yeasts

1997

NAD(P)H:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity.

The Journal of biological chemistry, 2000, Feb-25, Volume: 275, Issue:8

Topics: Antibiotics, Antineoplastic; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Division; Cytochrome Reductases; Cytochrome-B(5) Reductase; Dicumarol; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Flow Cytometry; Humans; Models, Biological; NAD; NADH, NADPH Oxidoreductases; NADPH-Ferrihemoprotein Reductase; Naphthoquinones; Proteins; Quinone Reductases; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Vitamin K

2000